[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356341-105":59,"doc-detail-356341-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integration-of-single-cell-sequencing-transcriptome-sequencing-and-machine-learning-for-constructing-and-validating-histone-acetylation-related-prognostic-risk-models-in-hepatocellular-carcinoma","Integration of single-cell sequencing, transcriptome sequencing, and machine learning for constructing and validating histone acetylation-related prognostic risk models in hepatocellular carcinoma","","Hepatocellular carcinoma (LIHC) remains lethal despite therapeutic advances, and the systemic role of histone acetylation in LIHC prognosis is unclear. This study integrates LIHC single-cell/RNA-seq data with histone acetylation-related gene sets to build an 11-gene, machine-learning prognostic risk model using 101 algorithms. The model is validated through survival, pathway, immune landscape, chemosensitivity, mutation, ferroptosis, and m6A analyses, and key findings are supported by in vitro and clinical assays.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integration-of-single-cell-sequencing-transcriptome-sequencing-and-machine-learning-for-constructing-and-validating-histone-acetylation-related-prognostic-risk-models-in-hepatocellular-carcinoma/356341/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integration-of-single-cell-sequencing-transcriptome-sequencing-and-machine-learning-for-constructing-and-validating-histone-acetylation-related-prognostic-risk-models-in-hepatocellular-carcinoma/356341.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and gene sets are integrated to construct the LIHC risk model?","Question",{"text":112,"@type":113},"The study integrates LIHC single-cell/RNA-seq data with histone acetylation-related gene sets to build a histone acetylation-related prognostic risk model.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prognostic risk model evaluated?",{"text":117,"@type":113},"The model’s value was assessed using prognostic analysis, pathway enrichment, immune landscape profiling, chemosensitivity, mutation analysis, ferroptosis, and m6A methylation analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biomarker is identified as a key risk factor and therapeutic target?",{"text":121,"@type":113},"NEU1 is identified as a key risk factor, with high expression linked to altered cell communication, and experimental validation showing that NEU1 knockdown reduces LIHC proliferation, migration, invasion, and tumor growth.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356341,1790210649,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","TYPE Original Research PUBLISHED 23 January 2026  \nDOI 10.3389/fimmu.2026.1624883  \nOPEN ACCESS  \nEDITED BY  \nArunasree M Kalle,  \nUniversity of Hyderabad, India  \nREVIEWED BY  \nSilvia Liu,  \nUniversity of Pittsburgh, United States Xuefeng Gu,  \nJiangsu University, China  \n*CORRESPONDENCE  \nQian Wang  \n [wangqian9797@xjtu.edu.cn](wangqian9797@xjtu.edu.cn)[ ](wangqian9797@xjtu.edu.cn)Puyi He  \n [hepy2023@lzu.edu.cn](hepy2023@lzu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 08 May 2025  \nREVISED 28 December 2025  \nACCEPTED 06 January 2026  \nPUBLISHED 23 January 2026  \nCITATION  \nQi Y, Wang F, Ren W, Cai C, Zhou Y, Zhu P, He P and Wang Q (2026) Integration of single-cell sequencing, transcriptome sequencing, and machine learning for constructing and validating histone acetylation-related prognostic risk models in hepatocellular carcinoma.  \nFront. Immunol. 17:1624883 .  \ndoi: 10.3389/fimmu.2026.1624883  \nCOPYRIGHT  \n© 2026 Qi, Wang, Ren, Cai, Zhou, Zhu, He and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIntegration of single-cell sequencing, transcriptome sequencing, and machine learning for constructing and validating histone acetylationrelated prognostic risk models in hepatocellular carcinoma  \nYajie Qi 1,2, Fulin Wang 1,2, Wenchao Ren 3, Chuanxu Cai 1,2,  \nYichen Zhou 1,2, Pengpeng Zhu 1,2, Puyi He 4*† and Qian Wang 1,2*†  \n1 National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Afﬁliated Hospital of Xi’an Jiaotong University, Xi’an, China, 2Tumor and Immunology Center of Precision Medicine Institute, Xi’an Jiaotong University, Xi’an, China, 3General Surgery, The Second Afﬁliated Hospital of Dalian Medical University, Dalian, China, 4General Surgery, The Second Hospital of Lanzhou University, Lanzhou, China  \nBackground: Liver hepatocellular carcinoma (LIHC), a prevalent gastrointestinal malignancy, continues to demonstrate poor prognosis despite therapeutic advances improving clinical outcomes. Histone acetylation, a key epigenetic modiﬁcation, regulates critical processes including chromatin remodeling, gene expression and drives tumor progression in multiple cancers (e.g., lung, gastric) yet its systemic role in LIHC remains unclear.  \nMethods: This study integrated LIHC single-cell/RNA-seq data and histone acetylation-related gene sets to construct a LIHC risk prediction model based on histone acetylation-related genes using 101 machine learning combinatorial algorithms. The model ’s comprehensive value was evaluated through prognostic analysis, pathway enrichment analysis, immune landscape analysis, chemosensitivity analysis, mutation analysis, ferroptosis, and m6A methylation analysis. NEU1 ’ s functional role was investigated via cell communication networks and molecular docking. Experimental validation included in vitro assays (Cell Counting Kit-8, migration, invasion), and clinical sample veriﬁcation (quantitative real-time PCR (qRT-PCR) and Western Blot (WB)); these were performed to validate the key ﬁndings.  \nResults: Using 101 machine learning combinations, we constructed an 11-gene LIHC risk model (HLA-B, HEXB, CDK4, ACAT1, NAA10, B2M, HSPD1, NPM1, PON1, NEU1, CFB) demonstrating robust prognostic accuracy across training/validation cohorts and 10 LIHC subtypes. Immune landscape analysis revealed that the high-risk group exhibited higher tumor purity and lower immune inﬁltration, with better responses to PD-L1 and PD-L2 treatment. Chemosensitivity analysis showed that the high-risk group had increased sensitivity to four drugs, including","cbCaivno6g61yIbD","https://ap.wps.com/l/cbCaivno6g61yIbD","pdf",45253672,25,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What data and gene sets are integrated to construct the LIHC risk model?\",\"answer\":\"The study integrates LIHC single-cell/RNA-seq data with histone acetylation-related gene sets to build a histone acetylation-related prognostic risk model.\"},{\"question\":\"How was the prognostic risk model evaluated?\",\"answer\":\"The model’s value was assessed using prognostic analysis, pathway enrichment, immune landscape profiling, chemosensitivity, mutation analysis, ferroptosis, and m6A methylation analyses.\"},{\"question\":\"Which biomarker is identified as a key risk factor and therapeutic target?\",\"answer\":\"NEU1 is identified as a key risk factor, with high expression linked to altered cell communication, and experimental validation showing that NEU1 knockdown reduces LIHC proliferation, migration, invasion, and tumor growth.\"}]","Integration of single-cell sequencing, transcriptome sequencing, and machine learning for constructing and validating histone acetylation-related prognostic risk models in hepatocellular carcinoma | PDF",1790124928,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a37e2abda5518423a2946eb9cfa6d380.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01d4e86b5623eba59319e61e3ec2478e.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dd65c06b723b61840be011a2c8d3f4f.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8131f450bb86df9ab50ec75847f35d2.webp",980,1385]